2012
DOI: 10.1016/j.clcc.2012.01.006
|View full text |Cite
|
Sign up to set email alerts
|

The Prevalence of Thyroid Cancer and Benign Thyroid Disease in Patients With Familial Adenomatous Polyposis May Be Higher Than Previously Recognized

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
23
0
2

Year Published

2013
2013
2018
2018

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 52 publications
(26 citation statements)
references
References 23 publications
1
23
0
2
Order By: Relevance
“…No clear recommendations exist for prospective screening (outside of routine physical examination) in most cases. However, updated recommendations for US screening have been put forth for both the PTEN hamartoma tumor syndrome and APC-associated polyposis (91,92,106). In addition, in nonsyndromic FNMTC, US surveillance of family members has been shown to detect earlier stages of disease as reflected by smaller tumor size (0.8 vs. 2.85 cm; p < 0.001), a lower incidence of lymph node metastasis (23.2% vs. 65.6%; p < 0.001) as well as a lower incidence of ETE (20.9% vs. 56.2%; p = 0.002) compared to the proband (107).…”
Section: In Children With Dtcmentioning
confidence: 99%
“…No clear recommendations exist for prospective screening (outside of routine physical examination) in most cases. However, updated recommendations for US screening have been put forth for both the PTEN hamartoma tumor syndrome and APC-associated polyposis (91,92,106). In addition, in nonsyndromic FNMTC, US surveillance of family members has been shown to detect earlier stages of disease as reflected by smaller tumor size (0.8 vs. 2.85 cm; p < 0.001), a lower incidence of lymph node metastasis (23.2% vs. 65.6%; p < 0.001) as well as a lower incidence of ETE (20.9% vs. 56.2%; p = 0.002) compared to the proband (107).…”
Section: In Children With Dtcmentioning
confidence: 99%
“…[5][6][7][8][9][10][11][12] Prospective registry screening programs for TC in FAP patients have reported incidences of 2.6% to 7%, 12,13 compared with .01% to .2% in the general population. 9,14 As a result of these findings and a retrospective review of our registry data, which demonstrated a prevalence rate of 6.1% for TC, 15 we began offering screening thyroid ultrasound (US) to our patients affected by adenomatous polyposis syndromes. We now report on our findings to enrich the cohort of patients with these rare syndromes.…”
mentioning
confidence: 99%
“…Other collective studies on FAP-TC have described prevalence rates ranging from 1.2% to 12% [2326]. Cumulative analysis suggests that as patients undergo systematic screening and ultrasound examinations, the rate of FAP-TC may be higher than previously expected [24,25]. …”
Section: Discussionmentioning
confidence: 99%